Notice: This company has been marked as potentially delisted and may not be actively trading. InVivo Therapeutics (NVIV) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Spinal Cord Injury Treatment Market Size to Worth USD 11 Bn by 2032August 9, 2024 | finance.yahoo.comInVivo Therapeutics Holdings Co (NVIVQ)May 26, 2024 | finance.yahoo.comInVivo Therapeutics Holdings Corp (NVIVQ)May 17, 2024 | investing.comGut health supplements are everywhere – but which are the best ones for *you*?March 28, 2024 | msn.comInVivo Therapeutics Holdings CorporationFebruary 15, 2024 | cnn.comInVivo Therapeutics Holdings Corp.February 14, 2024 | wsj.comFirm Retention Summary: InVivo Therapeutics HoldingsFebruary 13, 2024 | wsj.comInVivo Therapeutics Holdings Corp (NVIV)February 7, 2024 | investing.comBob Langer-founded device-maker declares bankruptcyFebruary 6, 2024 | bizjournals.comTrading was temporarily halted for "NVIV" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 6, 2024 | marketbeat.comTrading was temporarily halted for "NVIV" at 11:02 AM with a stated reason of "LULD pause."February 6, 2024 | marketbeat.comWhy Is InVivo Therapeutics (NVIV) Stock Up 61% Today?February 6, 2024 | investorplace.comInVivo Therapeutics Shares Plumb New Depths After Bankruptcy FilingFebruary 1, 2024 | marketwatch.comTrading was temporarily halted for "NVIV" at 07:02 AM with a stated reason of "News pending."February 1, 2024 | marketbeat.comInVivo Therapeutics Holdings Corp NVIVNovember 10, 2023 | morningstar.comSpinal Cord Trauma Treatment Market Analysis: Examining Trends and Forecasting Revenue Growth with an estimated CAGR 6.2% from 2023-2030June 22, 2023 | marketwatch.comRing Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate StrategyMay 1, 2023 | benzinga.comWhy InVivo Therapeutics Shares Are Plunging TodayMarch 17, 2023 | finance.yahoo.comInVivo seeks longer-term control in Casino-Teract retail tie-upMarch 10, 2023 | msn.comWhy Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving PremarketMarch 10, 2023 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%March 10, 2023 | msn.comWhy JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionMarch 9, 2023 | msn.comInVivo : INSPIRE 2.0 Study In Acute Spinal Cord Injury Fails To Meet Primary EndpointMarch 9, 2023 | markets.businessinsider.comInVivo to evaluate strategic options as trial for spinal injury device failsMarch 9, 2023 | msn.comInVivo Therapeutics Shares Hit 52-Week Low After Study Misses Primary EndpointMarch 9, 2023 | marketwatch.comInVivo Therapeutics Study for Neuro-Spinal Scaffold Misses Primary EndpointMarch 9, 2023 | marketwatch.comInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryMarch 9, 2023 | finance.yahoo.comTrading was temporarily halted for "NVIV" at 08:03 AM with a stated reason of "News pending."March 9, 2023 | marketbeat.comInVivo Therapeutics Hldg Stock (NASDAQ:NVIV), Quotes and News SummaryJanuary 11, 2023 | benzinga.comInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesOctober 11, 2022 | finance.yahoo.comInVivo Therapeutics Shares Continue Friday's Fall, Hit All-Time Intraday LowOctober 10, 2022 | marketwatch.comInVivo Therapeutics dips 24% on $9M direct and private placement offeringsOctober 7, 2022 | seekingalpha.comInVivo Therapeutics Stock Drops on $9 Million OfferingOctober 7, 2022 | marketwatch.comWhy Is InVivo Therapeutics (NVIV) Stock Down 34% Today?October 7, 2022 | investorplace.comInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesOctober 7, 2022 | finance.yahoo.comTrading was temporarily halted for "NVIV" at 03:10 PM with a stated reason of "LULD pause."October 6, 2022 | marketbeat.comInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 9, 2022 | finance.yahoo.comInVivo Therapeutics Holdings Corp. (NVIV)August 28, 2022 | uk.finance.yahoo.comTrading was temporarily halted for "NVIV" at 09:08 AM with a stated reason of "LULD pause."August 5, 2022 | marketbeat.comTrading was temporarily halted for "NVIV" at 10:08 AM with a stated reason of "LULD pause."August 4, 2022 | marketbeat.comTrading was temporarily halted for "NVIV" at 10:08 AM with a stated reason of "LULD pause." Trading set to resume at 10:08 AM. August 4, 2022 | marketbeat.comTrading was temporarily halted for "NVIV" at 10:08 AM with a stated reason of "LULD pause."August 4, 2022 | marketbeat.comTrading was temporarily halted for "NVIV" at 09:08 AM with a stated reason of "LULD pause."August 4, 2022 | marketbeat.comTrading was temporarily halted for "NVIV" at 09:08 AM with a stated reason of "LULD pause."August 4, 2022 | marketbeat.comInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General CounselJuly 13, 2022 | finance.yahoo.comInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryJune 8, 2022 | finance.yahoo.comInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury StudyJune 2, 2022 | finance.yahoo.comWhy Are InVivo Therapeutics Shares Trading Lower During Premarket Monday?April 18, 2022 | finance.yahoo.comWhy InVivo Therapeutics Stock Falling?April 15, 2022 | nasdaq.comInVivo Therapeutics Announces 1-for-25 Reverse Stock SplitApril 14, 2022 | marketwatch.com Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Your bank is lying to you. (Ad)You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts. View the best savings account rates here NVIV Media Mentions By Week NVIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVIV News Sentiment▼0.790.60▲Average Medical News Sentiment NVIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVIV Articles This Week▼00▲NVIV Articles Average Week Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STSS News SNOA News AMIX News INVO News BJDX News VERO News AVGR News GCTK News AFIB News DYNT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVIV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InVivo Therapeutics Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InVivo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVIV Stock Alerts